Skip to main content

Randomized, Double-Blind, Placebo-Controlled Trial, with Cross-Over, of Posoleucel for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation

Clinical Trial Grant
Duke Scholars

Administered By

Pediatrics, Transplant and Cellular Therapy

Awarded By

Allovir, Inc.

Start Date

October 28, 2022

End Date

October 14, 2024
 

Administered By

Pediatrics, Transplant and Cellular Therapy

Awarded By

Allovir, Inc.

Start Date

October 28, 2022

End Date

October 14, 2024